Role of molecular imaging in management of nonhypersecreting adrenal masses.
Lawson
M A
MA
Samarian PET Center, Phoenix, Arizona 85006, USA.
D015071:19-Iodocholesterol / Q000031:analogs & derivatives*; D019797:3-Iodobenzylguanidine; D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism; D019788:Fluorodeoxyglucose F18; D006801:Humans; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity
C023033:I-norcholesterol; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D015071:19-Iodocholesterol; D019797:3-Iodobenzylguanidine